Back to Journals » Drug Design, Development and Therapy » Volume 13

Hyperprogression after anti-programmed cell death ligand-1 therapy in a patient with recurrent metastatic urothelial bladder carcinoma following first-line cisplatin-based chemotherapy: a case report

Total article views   HTML views PDF downloads Totals
10,037 Dovepress* 8,177+ 1,643 9,820
PubMed Central* 1,860 510 2,370
Totals 10,037 2,153 12,190
*Since 11 January 2019
Total mentioned Facebook Delicious Reddit Twitter Others
10 0 0 0 3 7

View citations on PubMed Central and Google Scholar